Stay updated on Spartalizumab Combinations in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Spartalizumab Combinations in Melanoma Clinical Trial page.

Latest updates to the Spartalizumab Combinations in Melanoma Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.5.4 is now shown as the latest revision in the record history, replacing the previous v3.5.3.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page’s UI revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site software update rather than a change to the underlying study record.SummaryDifference0.1%

- Check31 days agoChange DetectedAdded revision v3.5.2 to the record history and removed revision v3.5.0.SummaryDifference0.1%

- Check59 days agoChange DetectedThe record history adds Revision: v3.5.0 and removes Revision: v3.4.3.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision entry v3.4.3 was added and v3.4.2 was removed in the record history.SummaryDifference0.1%

- Check95 days agoChange DetectedA new revision entry (v3.4.2) was added to the history. The funding-status notice associated with v3.4.1 was removed.SummaryDifference0.4%

Stay in the know with updates to Spartalizumab Combinations in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Spartalizumab Combinations in Melanoma Clinical Trial page.